Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 20.80
-0.20 (-0.95%)
Feb 23, 2026, 4:09 PM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 503.61 million as of February 23, 2026. Its market cap has increased by 14.05% in one year.
Market Cap
503.61M
Enterprise Value
637.67M
Revenue
565.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.80
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 503.61M, an increase of 350.88%. That is a compound annual growth rate of 7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 503.61M | -11.76% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.82B |
| Nordhealth AS | 2.41B |
| Photocure ASA | 1.57B |
| Thor Medical ASA | 1.55B |
| Vistin Pharma ASA | 944.54M |
| Omda AS | 797.75M |
| Lytix Biopharma AS | 693.81M |
| Gentian Diagnostics ASA | 684.75M |